A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.

Source:http://linkedlifedata.com/resource/pubmed/id/18345545

Download in:

View as

General Info

PMID
18345545